U.S. FDA authorizes IQOS as a modified risk tobacco product
PMI's smoke-free innovation becomes the first and only electronic nicotine product to receive such authorization.
In the news
As part of our “Spotlight” series on the inspirational employees driving our transformation, we meet Natalia Gomez, IT Manager in Colombia – and night-time novelist.Read more
The platform built by Philip Morris Germany and Austria helps candidates answer the age-old question: “Tell me about yourself.”Read more
A new survey reveals a quarter of respondents throw used cigarettes on the ground – but three in four want to help tackle the issueRead more
This is the first time Philip Morris International (PMI) has evolved its traditional sustainability reporting into an integrated overview.Read more
Meet the inspirational leaders using their experience to create positive work environments during these challenging times.Read more
The Board’s letter to shareholders encapsulates PMI’s commitment to a smoke-free futureRead more
Company establishes guiding principles for its peopleRead more
The Canadian biopharmaceutical company announces leap forward in developing a vaccine for COVID-19Read more
Vapes are smoke-free alternatives that – if they are scientifically substantiated and regulated to an appropriate standard – are a better choice for adult smokers who would otherwise continue to smoke.Read more
In the spotlight
Why cigarette sales are declining in Japan
Independent research shows that cigarette sales are significantly reduced when a smoke-free alternative is introduced in a large market.3 min read
Why invest in PMI?
We've built the world's most successful cigarette company. Now we're building our future on smoke-free products that are much better choices.
Share Price PM (Common Stock)
Latest News & Press ReleasesMedia Center
PMI Announces Keynote Speeches at International Forums During UN General Assembly
Why science must come first during UNGA 2020
Public Wants Greater Focus on Science-Based Decision-Making Says New International Survey from Philip Morris International
“In Support of the Primacy of Science”: PMI releases its white paper calling for a future based on scientific evidence.